Literature DB >> 21667088

Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.

Hiroshi Watabe1, Sanae Abe2, Takeshi Yoshitomi2.   

Abstract

PURPOSE: In normotensive eyes, reduced ocular blood flow can lead to glaucoma pathogenesis. Drugs that reduce intraocular pressure (IOP) often cause vasodilation of the ciliary arteries and improve blood flow to the eye. A novel class of drugs called Rho-associated coiled coil-forming protein kinase (ROCK) inhibitors can lower IOP. Therefore, we tested the ability of two ROCK inhibitors, Y-27632 and Y39983, to relax rabbit ciliary arteries.
METHODS: We measured in vitro ciliary artery smooth muscle contractions by isometric tension recordings and changes of intracellular free calcium concentration ([Ca(2+)](i)) by fluorescence photometry.
RESULTS: Both Y-27632 and Y-39983 induced a concentration-dependent relaxation in rabbit ciliary arteries precontracted with a high-potassium (high-K) solution. The amplitude of relaxation induced by Y-27632 and Y-39983 was not affected by either 100 μM N (G)-nitro-L: -arginine methyl ester (L: -NAME) or 10 μM indomethacin. In Ca(2+)-free solution, Y-27632 and Y-39983 significantly inhibited the transient contraction of ciliary arteries induced by 10 μM histamine. However, neither Y-27632 nor Y-39983 affected the elevation of [Ca(2+)](i) induced by high-K solution and histamine.
CONCLUSIONS: We concluded that Y-27632 and Y-39983 relaxed isolated rabbit ciliary artery segments in vitro. The mechanism of relaxation was not dependent on endothelial-derived factors such as nitric oxide (NO) or prostacyclin, nor was it dependent on changes in intracellular Ca(2+) concentration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667088     DOI: 10.1007/s10384-011-0048-9

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  36 in total

1.  Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity.

Authors:  Rudolf Schubert; Vjatscheslav U Kalentchuk; Ulrike Krien
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08-29       Impact factor: 4.733

2.  Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs.

Authors:  K Iizuka; Y Shimizu; H Tsukagoshi; A Yoshii; T Harada; K Dobashi; T Murozono; T Nakazawa; M Mori
Journal:  Eur J Pharmacol       Date:  2000-10-13       Impact factor: 4.432

3.  Mechanical properties of vascular smooth muscle cells in situ.

Authors:  M J Mulvany; W Halpern
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

4.  Effects of beta antagonists on mechanical properties in rabbit ciliary artery.

Authors:  R Hayashi-Morimoto; T Yoshitomi; H Ishikawa; E Hayashi; Y Sato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-08       Impact factor: 3.117

5.  Effect and mechanism of betaxolol and timolol on vascular relaxation in isolated rabbit ciliary artery.

Authors:  Yaru Dong; Hitoshi Ishikawa; Yazhen Wu; Kimiya Shimizu; Toshiaki Goseki; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2006-12-18       Impact factor: 2.447

6.  Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway.

Authors:  K Chitaley; C J Wingard; R Clinton Webb; H Branam; V S Stopper; R W Lewis; T M Mills
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

7.  Effect of ACh on electrical and mechanical activity in guinea pig coronary arteries.

Authors:  K D Keef; S M Bowen
Journal:  Am J Physiol       Date:  1989-10

8.  Ca2+ sensitization in contraction of human bladder smooth muscle.

Authors:  Ryosuke Takahashi; Junji Nishimura; Katsuya Hirano; Narihito Seki; Seiji Naito; Hideo Kanaide
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

9.  Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.

Authors:  Yaru Dong; Hitoshi Ishikawa; Yazhen Wu; Takeshi Yoshitomi
Journal:  Exp Eye Res       Date:  2007-01-27       Impact factor: 3.467

10.  Vasorelaxing effect of the Rho-kinase inhibitor, Y-27632, in isolated canine basilar arteries.

Authors:  Yasuhiro Hashiba; Masahiko Tosaka; Nobuhito Saito; Hideaki Imai; Tatsuya Shimizu; Tomio Sasaki
Journal:  Neurol Res       Date:  2007-07       Impact factor: 2.448

View more
  12 in total

1.  Regeneration of optic nerve fibers with unoprostone, a prostaglandin-related antiglaucoma drug, in adult cats.

Authors:  Hiroe Sagawa; Hiroko Terasaki; Keiko Nakanishi; Yoshihito Tokita; Masami Watanabe
Journal:  Jpn J Ophthalmol       Date:  2013-10-16       Impact factor: 2.447

Review 2.  Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.

Authors:  Megumi Honjo; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2018-02-14       Impact factor: 2.447

3.  Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.

Authors:  Yusuke Ohta; Sanae Takaseki; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2017-06-26       Impact factor: 2.447

Review 4.  Discovery of novel inhibitors for the treatment of glaucoma.

Authors:  Kishore Cholkar; Hoang M Trinh; Dhananjay Pal; Ashim K Mitra
Journal:  Expert Opin Drug Discov       Date:  2015-01-09       Impact factor: 6.098

Review 5.  Status of Rho kinase inhibitors in glaucoma therapeutics-an overview.

Authors:  Bhawesh Chandra Saha; Rashmi Kumari; Rakhi Kushumesh; Anita Ambasta; Bibhuti Prasanna Sinha
Journal:  Int Ophthalmol       Date:  2021-08-27       Impact factor: 2.031

6.  Addition of ROCK inhibitors to prostaglandin derivative (PG) synergistically affects adipogenesis of the 3D spheroids of human orbital fibroblasts (HOFs).

Authors:  Fumihito Hikage; Hanae Ichioka; Megumi Watanabe; Araya Umetsu; Hiroshi Ohguro; Yosuke Ida
Journal:  Hum Cell       Date:  2021-09-30       Impact factor: 4.174

Review 7.  Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.

Authors:  Angelo P Tanna; Mark Johnson
Journal:  Ophthalmology       Date:  2018-07-12       Impact factor: 12.079

8.  Pooled Efficacy and Safety Profile of Netarsudil Ophthalmic Solution 0.02% in Patients With Open-angle Glaucoma or Ocular Hypertension.

Authors:  Inder P Singh; Robert D Fechtner; Jonathan S Myers; Terry Kim; Dale W Usner; Hayley McKee; Huan Sheng; Richard A Lewis; Theresa Heah; Casey C Kopczynski
Journal:  J Glaucoma       Date:  2020-10       Impact factor: 2.290

9.  Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension.

Authors:  Makoto Araie; Kazuhisa Sugiyama; Kenji Aso; Koji Kanemoto; Kalyani Kothapalli; Casey Kopczynski; Michelle Senchyna; David A Hollander
Journal:  Adv Ther       Date:  2021-02-24       Impact factor: 3.845

10.  Diverse effects of pan-ROCK and ROCK2 inhibitors on 2 D and 3D cultured human trabecular meshwork (HTM) cells treated with TGFβ2.

Authors:  Megumi Watanabe; Yosuke Ida; Hiroshi Ohguro; Chiaki Ota; Fumihito Hikage
Journal:  Sci Rep       Date:  2021-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.